MyFinsight
Home
Blog
About
Vision Care
$270M
(-64.14%↓ Y/Y)
Surgical
$254M
(17.59%↑ Y/Y)
Revenue From Contract
With Customer...
$497M
Pharmaceuticals
$299M
(-3.24%↓ Y/Y)
Vision Care
$1M
(-99.87%↓ Y/Y)
Pharmaceuticals
$55M
(-82.20%↓ Y/Y)
Vision Care
$13M
(-98.27%↓ Y/Y)
Vision Care
$3M
(-99.60%↓ Y/Y)
Surgical
$2M
(-99.07%↓ Y/Y)
Net loss
attributable to bausch + lomb...
-$14M
(77.42%↑ Y/Y)
Device Products
$524M
Overthe Counter
Products
$497M
Pharmaceutical Products
$300M
Brandedand Other Generic
Products
$68M
Other Revenues
$5M
Net loss
-$10M
(82.76%↑ Y/Y)
Net income
attributable to...
$4M
(0.00%↑ Y/Y)
Benefit from (provision
for) income taxes
-$1M
(98.88%↑ Y/Y)
Total revenues
$1,394M
(9.08%↑ Y/Y)
Gain before
provision for income taxes
-$11M
(92.52%↑ Y/Y)
Operating income (loss)
$83M
(854.55%↑ Y/Y)
Interest income
$4M
(33.33%↑ Y/Y)
Total expenses
$1,311M
(1.71%↑ Y/Y)
Interest expense
$93M
(-27.34%↓ Y/Y)
Foreign exchange and
other
-$5M
(-150.00%↓ Y/Y)
Selling, general and
administrative (note 4)
$588M
(1.55%↑ Y/Y)
Cost of goods sold
(excluding amortization...
$527M
(0.76%↑ Y/Y)
Research and development
$114M
(18.75%↑ Y/Y)
Amortization of intangible
assets
$57M
(-14.93%↓ Y/Y)
Other expense, net
-$25M
(-13.64%↓ Y/Y)
Back
Back
Income Statement
Bausch & Lomb Corp (BLCO)
Bausch & Lomb Corp (BLCO)
source: myfinsight.com